| Title: |
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer |
| Authors: |
Verhoek, AndreAff1, IDs41669023003960_cor1; Cheema, ParneetAff2; Melosky, BarbaraAff3; Samson, BenoitAff4; Shepherd, Frances A.Aff5; de Marinis, FilippoAff6; John, ThomasAff7; Wu, Yi-LongAff8; Heeg, BartAff1; Van Dalfsen, NadiaAff1; Bracke, BenjaminAff9; Miranda, MiguelAff10; Shaw, SimonAff11; Moldaver, DanielAff12 |
| Source: |
PharmacoEconomics - Open: Healthcare Interventions and Outcomes. 7(3):455-467 |
| Database: |
Springer Nature Journals |